(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAFF mRNA] CTD PMID:31150632 (-)-anisomycin increases expression ISO RGD:1319919 6480464 Anisomycin results in increased expression of MAFF mRNA CTD PMID:24247028 (-)-demecolcine increases expression ISO RGD:1319919 6480464 Demecolcine results in increased expression of MAFF mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1319919 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MAFF mRNA CTD PMID:22079256 (E)-cinnamyl alcohol increases expression ISO RGD:1319919 6480464 cinnamyl alcohol results in increased expression of MAFF mRNA CTD PMID:20566472 1,1-dichloroethene increases expression ISO RGD:1319920 6480464 vinylidene chloride results in increased expression of MAFF mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:1319920 6480464 1, 2-Dimethylhydrazine results in decreased expression of MAFF mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1319920 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAFF mRNA CTD PMID:22206623 1,4-benzoquinone increases expression ISO RGD:1319919 6480464 quinone results in increased expression of MAFF mRNA CTD PMID:20491607 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1319919 6480464 Dinitrochlorobenzene results in increased expression of MAFF mRNA CTD PMID:20491607 , PMID:20566472 1-fluoro-2,4-dinitrobenzene increases expression ISO RGD:1319919 6480464 Dinitrofluorobenzene results in increased expression of MAFF mRNA CTD PMID:23999411 1-naphthyl isothiocyanate multiple interactions ISO RGD:1319919 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of MAFF mRNA CTD PMID:27344345 1-phenyl-1,2-propanedione increases expression ISO RGD:1319919 6480464 1-phenyl-1, 2-propanedione results in increased expression of MAFF mRNA CTD PMID:20491607 17alpha-ethynylestradiol affects expression ISO RGD:1319919 6480464 Ethinyl Estradiol affects the expression of MAFF mRNA CTD PMID:20170705 , PMID:26865667 17beta-estradiol increases expression ISO RGD:1319920 6480464 Estradiol results in increased expression of MAFF mRNA CTD PMID:25210133 17beta-estradiol decreases expression ISO RGD:1319919 6480464 Estradiol results in decreased expression of MAFF mRNA CTD PMID:31646340 17beta-estradiol increases expression ISO RGD:1319919 6480464 Estradiol results in increased expression of MAFF mRNA CTD PMID:19619570 more ... 17beta-estradiol multiple interactions ISO RGD:1319920 6480464 [Tetrachlorodibenzodioxin co-treated with Estradiol] results in decreased expression of MAFF mRNA CTD PMID:18691609 17beta-estradiol multiple interactions ISO RGD:1319919 6480464 [Estradiol co-treated with EGF protein] results in increased expression of MAFF mRNA more ... CTD PMID:19619570 more ... 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1319919 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1319920 6480464 Tetrachlorodibenzodioxin affects the expression of MAFF mRNA CTD PMID:21570461 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAFF mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MAFF mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1319920 6480464 Tetrachlorodibenzodioxin results in increased expression of MAFF mRNA CTD PMID:18691609 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1319919 6480464 Tetrachlorodibenzodioxin results in increased expression of MAFF mRNA CTD PMID:16704738 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1319919 6480464 Tetrachlorodibenzodioxin affects the expression of MAFF mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1319920 6480464 [Tetrachlorodibenzodioxin co-treated with Estradiol] results in decreased expression of MAFF mRNA more ... CTD PMID:18691609 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1319919 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of MAFF mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1319919 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAFF mRNA CTD PMID:19619570 2,3-dimethoxynaphthalene-1,4-dione increases expression ISO RGD:1319919 6480464 2 more ... CTD PMID:17547211 2-butoxyethanol increases expression ISO RGD:1319920 6480464 n-butoxyethanol results in increased expression of MAFF mRNA CTD PMID:19812364 2-hexenal increases expression ISO RGD:1319919 6480464 2-hexenal results in increased expression of MAFF mRNA CTD PMID:20491607 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1319919 6480464 3 more ... CTD PMID:19692669 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1319920 6480464 tetrabromobisphenol A results in increased expression of MAFF mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1319920 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of MAFF mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1319919 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAFF mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases expression ISO RGD:1319920 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of MAFF mRNA CTD PMID:33297965 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1319919 6480464 Oxazolone results in increased expression of MAFF mRNA CTD PMID:23999411 4-hydroxyphenyl retinamide increases expression ISO RGD:1319920 6480464 Fenretinide results in increased expression of MAFF mRNA CTD PMID:28973697 5-fluorouracil affects response to substance ISO RGD:1319919 6480464 MAFF protein affects the susceptibility to Fluorouracil CTD PMID:16217747 acrylamide increases expression ISO RGD:1319919 6480464 Acrylamide results in increased expression of MAFF mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:1319919 6480464 Aflatoxin B1 affects the expression of MAFF protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:1319919 6480464 Aflatoxin B1 results in increased methylation of MAFF exon CTD PMID:30157460 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of MAFF mRNA CTD PMID:25378103 aflatoxin B1 increases expression ISO RGD:1319919 6480464 Aflatoxin B1 results in increased expression of MAFF mRNA CTD PMID:27153756 aldehydo-D-glucose increases expression ISO RGD:1319920 6480464 Glucose results in increased expression of MAFF mRNA CTD PMID:17178593 all-trans-retinoic acid increases expression ISO RGD:1319919 6480464 Tretinoin results in increased expression of MAFF mRNA CTD PMID:21934132 , PMID:23724009 alpha-hexylcinnamaldehyde increases expression ISO RGD:1319919 6480464 hexyl cinnamic aldehyde results in increased expression of MAFF mRNA CTD PMID:20566472 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of MAFF mRNA CTD PMID:30779732 antimony(0) increases expression ISO RGD:1319919 6480464 Antimony results in increased expression of MAFF mRNA CTD PMID:17547211 antimycin A increases expression ISO RGD:1319919 6480464 Antimycin A results in increased expression of MAFF mRNA CTD PMID:33512557 arachidonic acid increases expression ISO RGD:1319919 6480464 Arachidonic Acid results in increased expression of MAFF mRNA CTD PMID:16704987 aristolochic acid increases expression ISO RGD:1319919 6480464 aristolochic acid I results in increased expression of MAFF mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1319919 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MAFF mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1319919 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MAFF mRNA CTD PMID:32525701 arsenite(3-) multiple interactions ISO RGD:1319920 6480464 [arsenite co-treated with Benzo(a)pyrene] results in increased expression of MAFF mRNA CTD PMID:15894712 arsenite(3-) multiple interactions ISO RGD:1319919 6480464 Fulvestrant inhibits the reaction [arsenite results in increased expression of MAFF mRNA] CTD PMID:31646340 arsenite(3-) increases expression ISO RGD:1319919 6480464 arsenite results in increased expression of MAFF mRNA CTD PMID:31646340 arsenite(3-) affects expression ISO RGD:1319919 6480464 arsenite affects the expression of MAFF mRNA CTD PMID:22959463 arsenite(3-) increases expression ISO RGD:1319920 6480464 arsenite results in increased expression of MAFF mRNA CTD PMID:15894712 arsenous acid increases expression ISO RGD:1319919 6480464 Arsenic Trioxide results in increased expression of MAFF mRNA, Arsenic Trioxide results in increased expression of MAFF protein CTD PMID:16487037 , PMID:26705709 atazanavir sulfate increases expression ISO RGD:1319919 6480464 Atazanavir Sulfate results in increased expression of MAFF mRNA CTD PMID:32152650 atazanavir sulfate multiple interactions ISO RGD:1319919 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFF mRNA CTD PMID:32152650 azathioprine increases expression ISO RGD:1319919 6480464 Azathioprine results in increased expression of MAFF mRNA CTD PMID:22623647 azoxystrobin decreases expression ISO RGD:1319919 6480464 azoxystrobin results in decreased expression of MAFF mRNA CTD PMID:33512557 Bandrowski's base increases expression ISO RGD:1319919 6480464 Bandrowski's base results in increased expression of MAFF mRNA CTD PMID:20566472 benzene increases expression ISO RGD:1319919 6480464 Benzene results in increased expression of MAFF mRNA CTD PMID:33064461 benzo[a]pyrene multiple interactions ISO RGD:1319920 6480464 [arsenite co-treated with Benzo(a)pyrene] results in increased expression of MAFF mRNA CTD PMID:15894712 benzo[a]pyrene increases methylation ISO RGD:1319919 6480464 Benzo(a)pyrene results in increased methylation of MAFF 5' UTR, Benzo(a)pyrene results in increased methylation of MAFF promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1319919 6480464 Benzo(a)pyrene results in increased expression of MAFF mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO RGD:1319920 6480464 Benzo(a)pyrene results in increased expression of MAFF mRNA CTD PMID:15894712 more ... benzo[a]pyrene diol epoxide I increases expression ISO RGD:1319919 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:1319920 6480464 benzo(b)fluoranthene results in increased expression of MAFF mRNA CTD PMID:26377693 benzo[d]isothiazol-3-one increases expression ISO RGD:1319919 6480464 1, 2-benzisothiazoline-3-one results in increased expression of MAFF mRNA CTD PMID:20491607 benzyl cinnamate increases expression ISO RGD:1319919 6480464 benzyl cinnamate results in increased expression of MAFF mRNA CTD PMID:20491607 beta-naphthoflavone increases expression ISO RGD:1319919 6480464 beta-Naphthoflavone results in increased expression of MAFF mRNA CTD PMID:32151702 bexarotene decreases expression ISO RGD:1319919 6480464 bexarotene results in decreased expression of MAFF mRNA CTD PMID:17178900 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MAFF promoter CTD PMID:23359474 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1319920 6480464 Diethylhexyl Phthalate results in decreased expression of MAFF mRNA CTD PMID:28085963 bisphenol A affects expression ISO RGD:1319919 6480464 bisphenol A affects the expression of MAFF mRNA CTD PMID:20170705 , PMID:30903817 bisphenol A decreases expression ISO RGD:1319919 6480464 bisphenol A results in decreased expression of MAFF protein CTD PMID:33376534 bisphenol A multiple interactions ISO RGD:1319919 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAFF mRNA CTD PMID:28628672 bisphenol A affects methylation ISO RGD:1319920 6480464 bisphenol A affects the methylation of MAFF promoter CTD PMID:27334623 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MAFF mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MAFF promoter CTD PMID:23359474 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of MAFF mRNA CTD PMID:32479839 buta-1,3-diene increases expression ISO RGD:1319920 6480464 1, 3-butadiene results in increased expression of MAFF mRNA CTD PMID:29038090 butanal increases expression ISO RGD:1319919 6480464 butyraldehyde results in increased expression of MAFF mRNA CTD PMID:26079696 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of MAFF mRNA CTD PMID:19167457 cadmium atom increases expression ISO RGD:1319919 6480464 Cadmium results in increased expression of MAFF mRNA CTD PMID:21120746 , PMID:31646340 cadmium dichloride increases expression ISO RGD:1319920 6480464 Cadmium Chloride results in increased expression of MAFF mRNA CTD PMID:20061341 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of MAFF mRNA CTD PMID:22110744 calcitriol increases expression ISO RGD:1319919 6480464 Calcitriol results in increased expression of MAFF mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1319919 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of MAFF mRNA CTD PMID:21592394 cannabidiol increases expression ISO RGD:1319919 6480464 Cannabidiol results in increased expression of MAFF mRNA CTD PMID:31518892 captan increases expression ISO RGD:1319920 6480464 Captan results in increased expression of MAFF mRNA CTD PMID:31558096 carbamazepine affects expression ISO RGD:1319919 6480464 Carbamazepine affects the expression of MAFF mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1319920 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1319920 6480464 Nanotubes, Carbon results in decreased expression of MAFF mRNA CTD PMID:25620056 chenodeoxycholic acid multiple interactions ISO RGD:1319919 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFF mRNA more ... CTD PMID:32152650 , PMID:33819548 chloroprene increases expression ISO RGD:1319920 6480464 Chloroprene results in increased expression of MAFF mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:1319920 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAFF gene CTD PMID:20938992 chromium atom increases expression ISO RGD:1319919 6480464 Chromium results in increased expression of MAFF mRNA CTD PMID:17547211 ciguatoxin CTX1B affects expression ISO RGD:1319920 6480464 Ciguatoxins affects the expression of MAFF mRNA CTD PMID:18353800 cinnamyl alcohol increases expression ISO RGD:1319919 6480464 cinnamyl alcohol results in increased expression of MAFF mRNA CTD PMID:20566472 cisplatin multiple interactions ISO RGD:1319919 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of MAFF mRNA CTD PMID:27392435 citral increases expression ISO RGD:1319919 6480464 citral results in increased expression of MAFF mRNA CTD PMID:20491607 clofibrate multiple interactions ISO RGD:1319920 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MAFF mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MAFF mRNA] CTD PMID:17585979 cobalt dichloride multiple interactions ISO RGD:1319919 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of MAFF mRNA] CTD PMID:22202117 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of MAFF mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:1319919 6480464 cobaltous chloride results in increased expression of MAFF mRNA CTD PMID:19376846 , PMID:22202117 cocaine increases expression EXP 6480464 Cocaine results in increased expression of MAFF mRNA CTD PMID:27899881 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of MAFF mRNA CTD PMID:26033743 copper atom multiple interactions ISO RGD:1319919 6480464 [NSC 689534 binds to Copper] which results in increased expression of MAFF mRNA, [Organoselenium Compounds binds to Copper] which results in increased expression of MAFF mRNA CTD PMID:20971185 , PMID:25167922 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of MAFF mRNA CTD PMID:26033743 copper(0) multiple interactions ISO RGD:1319919 6480464 [NSC 689534 binds to Copper] which results in increased expression of MAFF mRNA, [Organoselenium Compounds binds to Copper] which results in increased expression of MAFF mRNA CTD PMID:20971185 , PMID:25167922 copper(II) sulfate increases expression ISO RGD:1319919 6480464 Copper Sulfate results in increased expression of MAFF mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:1319919 6480464 Coumestrol results in decreased expression of MAFF mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1319919 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAFF mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1319919 6480464 Asbestos, Crocidolite results in increased expression of MAFF mRNA CTD PMID:18687144 crocidolite asbestos affects expression ISO RGD:1319919 6480464 Asbestos, Crocidolite affects the expression of MAFF mRNA CTD PMID:25757056 CU-O LINKAGE increases expression ISO RGD:1319919 6480464 cupric oxide results in increased expression of MAFF mRNA CTD PMID:22077320 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of MAFF mRNA CTD PMID:27523638 cyclosporin A increases expression ISO RGD:1319920 6480464 Cyclosporine results in increased expression of MAFF mRNA CTD PMID:23958496 cyclosporin A increases expression ISO RGD:1319919 6480464 Cyclosporine results in increased expression of MAFF mRNA CTD PMID:20106945 more ... cyclosporin A multiple interactions ISO RGD:1319919 6480464 [Cyclosporine co-treated with Cholic Acids] affects the expression of MAFF mRNA, [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFF mRNA CTD PMID:27344345 , PMID:32152650 cylindrospermopsin increases expression ISO RGD:1319919 6480464 cylindrospermopsin results in increased expression of MAFF mRNA CTD PMID:24921660 D-glucose increases expression ISO RGD:1319920 6480464 Glucose results in increased expression of MAFF mRNA CTD PMID:17178593 deoxycholic acid multiple interactions ISO RGD:1319919 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFF mRNA more ... CTD PMID:32152650 , PMID:33819548 deoxynivalenol increases expression ISO RGD:1319919 6480464 deoxynivalenol results in increased expression of MAFF mRNA CTD PMID:24247028 dexamethasone multiple interactions ISO RGD:1319919 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAFF mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:1319919 6480464 Arsenic Trioxide results in increased expression of MAFF mRNA, Arsenic Trioxide results in increased expression of MAFF protein CTD PMID:16487037 , PMID:26705709 diazinon increases methylation ISO RGD:1319919 6480464 Diazinon results in increased methylation of MAFF gene CTD PMID:22964155 dibenz[a,h]anthracene increases expression ISO RGD:1319920 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of MAFF mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MAFF promoter CTD PMID:23359474 dibutyl phthalate increases expression ISO RGD:1319920 6480464 Dibutyl Phthalate results in increased expression of MAFF mRNA CTD PMID:17361019 , PMID:21266533 diethyl maleate increases expression ISO RGD:1319919 6480464 diethyl maleate results in increased expression of MAFF mRNA CTD PMID:20491607 , PMID:33545341 diethyl sulfate increases expression ISO RGD:1319919 6480464 diethyl sulfate results in increased expression of MAFF mRNA CTD PMID:20491607 dioxygen multiple interactions ISO RGD:1319920 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAFF mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MAFF mRNA CTD PMID:33729688 diphenylcyclopropenone increases expression ISO RGD:1319919 6480464 diphenylcyclopropenone results in increased expression of MAFF mRNA CTD PMID:20491607 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate increases expression ISO RGD:1319919 6480464 Antimony Potassium Tartrate results in increased expression of MAFF mRNA CTD PMID:17547211 disulfiram increases expression ISO RGD:1319919 6480464 Disulfiram results in increased expression of MAFF mRNA CTD PMID:20566472 dorsomorphin multiple interactions ISO RGD:1319919 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1319920 6480464 Doxorubicin results in increased expression of MAFF mRNA CTD PMID:28608983 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of MAFF mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1319919 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAFF mRNA CTD PMID:19167446 eugenol increases expression ISO RGD:1319919 6480464 Eugenol results in increased expression of MAFF mRNA CTD PMID:20566472 fenamidone increases expression ISO RGD:1319920 6480464 fenamidone results in increased expression of MAFF mRNA CTD PMID:27029645 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of MAFF mRNA CTD PMID:30307764 fluoranthene multiple interactions ISO RGD:1319920 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of MAFF mRNA CTD PMID:28329830 fluorescein 5-isothiocyanate increases expression ISO RGD:1319919 6480464 Fluorescein-5-isothiocyanate results in increased expression of MAFF mRNA CTD PMID:20491607 folic acid multiple interactions ISO RGD:1319920 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folic acid decreases expression ISO RGD:1319920 6480464 Folic Acid results in decreased expression of MAFF mRNA CTD PMID:25629700 folpet increases expression ISO RGD:1319920 6480464 folpet results in increased expression of MAFF mRNA CTD PMID:31558096 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of MAFF mRNA CTD PMID:20884683 formaldehyde increases expression ISO RGD:1319919 6480464 Formaldehyde results in increased expression of MAFF mRNA CTD PMID:20655997 , PMID:23649840 fulvestrant multiple interactions ISO RGD:1319919 6480464 Estradiol inhibits the reaction [Fulvestrant results in increased expression of MAFF mRNA], Fulvestrant inhibits the reaction [arsenite results in increased expression of MAFF mRNA] CTD PMID:31646340 fulvestrant increases expression ISO RGD:1319919 6480464 Fulvestrant results in increased expression of MAFF mRNA CTD PMID:31646340 genistein decreases expression ISO RGD:1319919 6480464 Genistein results in decreased expression of MAFF mRNA CTD PMID:20884965 genistein increases expression ISO RGD:1319919 6480464 Genistein results in increased expression of MAFF mRNA CTD PMID:26865667 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MAFF mRNA CTD PMID:33387578 geranial increases expression ISO RGD:1319919 6480464 citral results in increased expression of MAFF mRNA CTD PMID:20491607 geraniol increases expression ISO RGD:1319919 6480464 geraniol results in increased expression of MAFF mRNA CTD PMID:27683099 glucose increases expression ISO RGD:1319920 6480464 Glucose results in increased expression of MAFF mRNA CTD PMID:17178593 glycochenodeoxycholic acid multiple interactions ISO RGD:1319919 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFF mRNA more ... CTD PMID:32152650 , PMID:33819548 glycocholic acid multiple interactions ISO RGD:1319919 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFF mRNA more ... CTD PMID:32152650 , PMID:33819548 glycodeoxycholic acid multiple interactions ISO RGD:1319919 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFF mRNA more ... CTD PMID:32152650 , PMID:33819548 Heliotrine increases expression ISO RGD:1319919 6480464 heliotrine results in increased expression of MAFF mRNA CTD PMID:26100227 hydrogen peroxide affects expression ISO RGD:1319919 6480464 Hydrogen Peroxide affects the expression of MAFF mRNA CTD PMID:20044591 hydrogen sulfide increases expression ISO RGD:1319920 6480464 Hydrogen Sulfide results in increased expression of MAFF mRNA CTD PMID:31843631 hydroquinone increases expression ISO RGD:1319919 6480464 hydroquinone results in increased expression of MAFF mRNA CTD PMID:31256213 hydroxycitronellal increases expression ISO RGD:1319919 6480464 hydroxycitronellal results in increased expression of MAFF mRNA CTD PMID:20491607 hypochlorous acid increases expression ISO RGD:1319919 6480464 Hypochlorous Acid results in increased expression of MAFF mRNA CTD PMID:18156441 indometacin multiple interactions ISO RGD:1319919 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAFF mRNA CTD PMID:28628672 isoeugenol increases expression ISO RGD:1319919 6480464 isoeugenol results in increased expression of MAFF mRNA CTD PMID:20491607 , PMID:20566472 isoprenaline increases expression ISO RGD:1319920 6480464 Isoproterenol results in increased expression of MAFF mRNA CTD PMID:20003209 isotretinoin decreases expression ISO RGD:1319919 6480464 Isotretinoin results in decreased expression of MAFF mRNA CTD PMID:20436886 L-ascorbic acid multiple interactions ISO RGD:1319919 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of MAFF mRNA CTD PMID:17639512 L-methionine multiple interactions ISO RGD:1319920 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAFF gene CTD PMID:20938992 lead(0) affects expression ISO RGD:1319919 6480464 Lead affects the expression of MAFF mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1319919 6480464 Lead affects the expression of MAFF mRNA CTD PMID:28903495 leflunomide increases expression ISO RGD:1319919 6480464 leflunomide results in increased expression of MAFF mRNA CTD PMID:28988120 Licochalcone B increases expression ISO RGD:1319919 6480464 licochalcone B results in increased expression of MAFF mRNA CTD PMID:33647349 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of MAFF mRNA CTD PMID:28801915 menadione affects expression ISO RGD:1319919 6480464 Vitamin K 3 affects the expression of MAFF mRNA CTD PMID:20044591 mercury atom increases expression ISO RGD:1319919 6480464 Mercury results in increased expression of MAFF mRNA CTD PMID:19937285 mercury dibromide multiple interactions ISO RGD:1319919 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAFF mRNA CTD PMID:27188386 mercury(0) increases expression ISO RGD:1319919 6480464 Mercury results in increased expression of MAFF mRNA CTD PMID:19937285 methamphetamine multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of MAFF mRNA CTD PMID:19564919 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of MAFF mRNA CTD PMID:19564919 methyl methanesulfonate increases expression ISO RGD:1319919 6480464 Methyl Methanesulfonate results in increased expression of MAFF mRNA CTD PMID:23649840 methyl non-2-ynoate increases expression ISO RGD:1319919 6480464 2-nonynoic acid methyl ester results in increased expression of MAFF mRNA CTD PMID:20491607 methylisothiazolinone increases expression ISO RGD:1319919 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of MAFF mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1319919 6480464 methylmercuric chloride results in increased expression of MAFF mRNA CTD PMID:23179753 more ... methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of MAFF mRNA CTD PMID:31378766 methylmercury chloride multiple interactions ISO RGD:1319919 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAFF mRNA CTD PMID:27188386 methyltestosterone multiple interactions ISO RGD:1319919 6480464 [Methyltestosterone co-treated with Cholic Acids] affects the expression of MAFF mRNA CTD PMID:27344345 mitoxantrone affects response to substance ISO RGD:1319919 6480464 MAFF mRNA affects the susceptibility to Mitoxantrone CTD PMID:16044152 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of MAFF mRNA CTD PMID:16809437 N-nitrosodiethylamine increases expression ISO RGD:1319920 6480464 Diethylnitrosamine results in increased expression of MAFF mRNA CTD PMID:24535843 N-nitrosodimethylamine increases expression ISO RGD:1319919 6480464 Dimethylnitrosamine results in increased expression of MAFF mRNA CTD PMID:17547211 n-propyl gallate increases expression ISO RGD:1319919 6480464 Propyl Gallate results in increased expression of MAFF mRNA CTD PMID:20491607 naphthalene increases expression EXP 6480464 naphthalene analog results in increased expression of MAFF mRNA CTD PMID:24976557 nefazodone increases expression ISO RGD:1319919 6480464 nefazodone results in increased expression of MAFF mRNA CTD PMID:32152650 nefazodone multiple interactions ISO RGD:1319919 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAFF mRNA CTD PMID:32152650 nickel dichloride increases expression ISO RGD:1319919 6480464 nickel chloride results in increased expression of MAFF mRNA CTD PMID:17547211 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of MAFF mRNA CTD PMID:22110744 nickel sulfate increases expression ISO RGD:1319920 6480464 nickel sulfate results in increased expression of MAFF mRNA CTD PMID:16166746 nickel sulfate increases expression ISO RGD:1319919 6480464 nickel sulfate results in increased expression of MAFF mRNA CTD PMID:18651567 , PMID:20566472 obeticholic acid increases expression ISO RGD:1319919 6480464 obeticholic acid results in increased expression of MAFF mRNA CTD PMID:27939613 organoselenium compound multiple interactions ISO RGD:1319919 6480464 [Organoselenium Compounds binds to Copper] which results in increased expression of MAFF mRNA CTD PMID:25167922 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MAFF mRNA CTD PMID:25729387 oxazepam increases expression ISO RGD:1319920 6480464 Oxazepam results in increased expression of MAFF mRNA CTD PMID:15618236 p-chloromercuribenzoic acid multiple interactions ISO RGD:1319919 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAFF mRNA CTD PMID:27188386 paracetamol multiple interactions ISO RGD:1319920 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MAFF mRNA more ... CTD PMID:17585979 , PMID:18700144 paracetamol multiple interactions ISO RGD:1319919 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of MAFF mRNA CTD PMID:33819548 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MAFF mRNA CTD PMID:32479839 , PMID:33387578 paracetamol increases expression ISO RGD:1319919 6480464 Acetaminophen results in increased expression of MAFF mRNA CTD PMID:21420995 , PMID:29067470 paracetamol affects expression ISO RGD:1319920 6480464 Acetaminophen affects the expression of MAFF mRNA CTD PMID:17562736 paraquat increases expression EXP 6480464 Paraquat results in increased expression of MAFF mRNA CTD PMID:32680482 pentanal increases expression ISO RGD:1319919 6480464 pentanal results in increased expression of MAFF mRNA CTD PMID:26079696 perfluorooctanoic acid increases expression ISO RGD:1319919 6480464 perfluorooctanoic acid results in increased expression of MAFF mRNA CTD PMID:25868421 perillyl aldehyde increases expression ISO RGD:1319919 6480464 perillaldehyde results in increased expression of MAFF mRNA CTD PMID:20491607 phenobarbital multiple interactions ISO RGD:1319920 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MAFF mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:1319919 6480464 Phenobarbital affects the expression of MAFF mRNA CTD PMID:19159669 phenobarbital increases expression ISO RGD:1319920 6480464 Phenobarbital results in increased expression of MAFF mRNA CTD PMID:19270015 , PMID:19482888 phenobarbital decreases expression ISO RGD:1319920 6480464 Phenobarbital results in decreased expression of MAFF mRNA CTD PMID:19270015 phenylmercury acetate increases expression ISO RGD:1319919 6480464 Phenylmercuric Acetate results in increased expression of MAFF mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1319919 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAFF mRNA CTD PMID:27188386 phosgene affects expression ISO RGD:1319920 6480464 Phosgene affects the expression of MAFF mRNA CTD PMID:16300373 phthalic anhydride increases expression ISO RGD:1319919 6480464 phthalic anhydride results in increased expression of MAFF mRNA CTD PMID:20491607 picoxystrobin decreases expression ISO RGD:1319919 6480464 picoxystrobin results in decreased expression of MAFF mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:1319920 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MAFF mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:1319920 6480464 pirinixic acid results in increased expression of MAFF mRNA CTD PMID:15618236 , PMID:18445702 potassium chromate increases expression ISO RGD:1319919 6480464 potassium chromate(VI) results in increased expression of MAFF mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1319919 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MAFF mRNA CTD PMID:22079256 potassium dichromate increases expression ISO RGD:1319919 6480464 Potassium Dichromate results in increased expression of MAFF mRNA, Potassium Dichromate results in increased expression of MAFF protein CTD PMID:17547211 , PMID:23718831 potassium dichromate increases expression ISO RGD:1319920 6480464 Potassium Dichromate results in increased expression of MAFF mRNA CTD PMID:23608068 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1319920 6480464 Pregnenolone Carbonitrile results in increased expression of MAFF mRNA CTD PMID:28903501 quercetin multiple interactions ISO RGD:1319919 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of MAFF mRNA CTD PMID:17639512 quercetin increases expression ISO RGD:1319919 6480464 Quercetin results in increased expression of MAFF mRNA CTD PMID:21632981 raloxifene multiple interactions ISO RGD:1319919 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of MAFF mRNA CTD PMID:19059307 resveratrol decreases expression ISO RGD:1319920 6480464 resveratrol results in decreased expression of MAFF protein CTD PMID:25505154 rifampicin multiple interactions ISO RGD:1319919 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of MAFF mRNA CTD PMID:21127053 rotenone increases expression ISO RGD:1319920 6480464 Rotenone results in increased expression of MAFF mRNA CTD PMID:23186747 rotenone decreases expression ISO RGD:1319919 6480464 Rotenone results in decreased expression of MAFF mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:1319919 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of MAFF mRNA CTD PMID:33725128 salicylic acid increases expression ISO RGD:1319919 6480464 Salicylic Acid results in increased expression of MAFF mRNA CTD PMID:20491607 SB 431542 multiple interactions ISO RGD:1319919 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SCH 23390 multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of MAFF mRNA CTD PMID:19564919 senecionine increases expression ISO RGD:1319919 6480464 senecionine results in increased expression of MAFF mRNA CTD PMID:26100227 Senkirkine increases expression ISO RGD:1319919 6480464 senkirkine results in increased expression of MAFF mRNA CTD PMID:26100227 silicon dioxide increases expression ISO RGD:1319919 6480464 Silicon Dioxide analog results in increased expression of MAFF mRNA, Silicon Dioxide results in increased expression of MAFF mRNA CTD PMID:25351596 , PMID:25895662 silicon dioxide increases expression ISO RGD:1319920 6480464 Silicon Dioxide results in increased expression of MAFF mRNA CTD PMID:19073995 more ... silver atom increases expression ISO RGD:1319919 6480464 Silver results in increased expression of MAFF mRNA CTD PMID:26014281 , PMID:28959546 silver(0) increases expression ISO RGD:1319919 6480464 Silver results in increased expression of MAFF mRNA CTD PMID:26014281 , PMID:28959546 sodium arsenate multiple interactions ISO RGD:1319919 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MAFF mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:1319919 6480464 sodium arsenite results in increased expression of MAFF mRNA CTD PMID:16966095 more ... sodium arsenite increases expression ISO RGD:1319920 6480464 sodium arsenite results in increased expression of MAFF mRNA CTD PMID:16014739 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of MAFF mRNA CTD PMID:22110744 sodium dichromate increases expression ISO RGD:1319920 6480464 sodium bichromate results in increased expression of MAFF mRNA CTD PMID:31558096 sodium dodecyl sulfate increases expression ISO RGD:1319919 6480464 Sodium Dodecyl Sulfate results in increased expression of MAFF mRNA CTD PMID:20491607 Soman increases expression EXP 6480464 Soman results in increased expression of MAFF mRNA CTD PMID:19281266 Sunset Yellow FCF multiple interactions ISO RGD:1319919 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of MAFF mRNA CTD PMID:33819548 tacrolimus hydrate increases expression ISO RGD:1319920 6480464 Tacrolimus results in increased expression of MAFF mRNA CTD PMID:23958496 tamoxifen multiple interactions ISO RGD:1319919 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of MAFF mRNA, ESR2 protein affects the reaction [Tamoxifen results in decreased expression of MAFF mRNA] CTD PMID:14699072 , PMID:19059307 tartrazine multiple interactions ISO RGD:1319919 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAFF mRNA CTD PMID:33819548 tert-butyl hydroperoxide increases expression ISO RGD:1319919 6480464 tert-Butylhydroperoxide results in increased expression of MAFF mRNA CTD PMID:15336504 testosterone increases expression ISO RGD:1319919 6480464 Testosterone results in increased expression of MAFF mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1319919 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of MAFF mRNA CTD PMID:21592394 tetrachloroethene increases expression ISO RGD:1319920 6480464 Tetrachloroethylene results in increased expression of MAFF mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO RGD:1319920 6480464 Carbon Tetrachloride results in increased expression of MAFF mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MAFF mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAFF mRNA] CTD PMID:31150632 thimerosal decreases expression ISO RGD:1319919 6480464 Thimerosal results in decreased expression of MAFF mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MAFF mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide increases expression ISO RGD:1319920 6480464 titanium dioxide results in increased expression of MAFF mRNA CTD PMID:27760801 topotecan increases expression EXP 6480464 Topotecan results in increased expression of MAFF mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MAFF mRNA CTD PMID:25729387 trans-isoeugenol increases expression ISO RGD:1319919 6480464 isoeugenol results in increased expression of MAFF mRNA CTD PMID:20491607 , PMID:20566472 triacsin C increases expression ISO RGD:1319919 6480464 triacsin C results in increased expression of MAFF mRNA CTD PMID:16704987 trichloroethene increases expression ISO RGD:1319920 6480464 Trichloroethylene results in increased expression of MAFF mRNA CTD PMID:28973375 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of MAFF mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1319919 6480464 trichostatin A results in increased expression of MAFF mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1319919 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAFF mRNA CTD PMID:27188386 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of MAFF mRNA CTD PMID:30589522 Triptolide affects expression ISO RGD:1319920 6480464 triptolide affects the expression of MAFF mRNA CTD PMID:32835833 triptonide increases expression ISO RGD:1319920 6480464 triptonide results in increased expression of MAFF mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:1319919 6480464 troglitazone results in increased expression of MAFF mRNA CTD PMID:19140230 tunicamycin increases expression ISO RGD:1319920 6480464 Tunicamycin results in increased expression of MAFF mRNA CTD PMID:17127020 tunicamycin increases expression ISO RGD:1319919 6480464 Tunicamycin results in increased expression of MAFF mRNA CTD PMID:33545341 urethane increases expression ISO RGD:1319919 6480464 Urethane results in increased expression of MAFF mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1319919 6480464 Valproic Acid affects the expression of MAFF mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1319919 6480464 Valproic Acid results in increased expression of MAFF mRNA CTD PMID:29154799 valsartan multiple interactions ISO RGD:1319919 6480464 Valsartan inhibits the reaction [AGT protein results in increased expression of MAFF mRNA] CTD PMID:19225232 vincristine increases expression ISO RGD:1319919 6480464 Vincristine results in increased expression of MAFF mRNA CTD PMID:23649840 vorinostat decreases expression ISO RGD:1319919 6480464 vorinostat results in decreased expression of MAFF mRNA CTD PMID:27188386 zinc atom multiple interactions ISO RGD:1319919 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MAFF mRNA CTD PMID:18593933 zinc dichloride multiple interactions ISO RGD:1319919 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of MAFF mRNA] CTD PMID:22202117 zinc(0) multiple interactions ISO RGD:1319919 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MAFF mRNA CTD PMID:18593933 zoledronic acid increases expression ISO RGD:1319919 6480464 zoledronic acid results in increased expression of MAFF mRNA CTD PMID:24714768